In this study, we evaluated ANXA10 expression in pancreatic tissues during the progression of pancreatic cancer by immunostaining analysis, which included normal pancreas, cancer adjacent normal tissues, chronic pancreatitis, IPMNs (low- and high-grades), PanINs (low- and high-grades) and PDACs at early- and late-stages. Here, ANXA10 is linked to cancer.